Clinical Trials
- Gynecological Cancers
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) Using a Novel "Prime and Pull" Strategy
- Ages18 years and older
- GenderFemale only
- Date06/13/2016
- Gynecological Cancers
A Phase II Evaluation of Afatinib
- Ages18 years and younger
- GenderFemale only
- Date05/24/2018
- Gynecological Cancers
A Phase II Study of Abemaciclib in Combination With Letrozole in Advanced, Recurrent or Metastatic Endometroid Endometrial Cancer
- Date02/16/2021
- Gynecological Cancers
A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer (KEYNOTE-A18 / ENGOT-cx11)
- Date12/03/2020
- Gynecological Cancers
A Phase II Evaluation of the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Persistent or Recurrent Endometrial Cancer
- Date06/23/2020
- Gynecological Cancers
A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma
- Ages18 years and older
- GenderFemale only
- Date03/24/2021
- Gynecological Cancers
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
- Ages18 years and older
- GenderFemale only
- Date07/14/2021
- Gynecological Cancers, Thyroid and Other Endocrine Cancers
Endometrium and Metabolism
- Date12/14/2018
- Gynecological Cancers, Non-Therapeutic
A Novel Tapered Applicator for Post-Hysterectomy Vaginal Vault Brachytherapy: Quality-of-Life Assessment of Patient Comfort and In Vivo Dosimetry
- Date07/16/2020
- Colorectal Cancer
S0820, Adenoma and Second Primary Prevention Trial (PACES)
- Ages18 years and older
- GenderBoth
- Date09/16/2020